CXU – Ten Minute Tissue™
Optimized For Tissue Integration
Conexeu Sciences' first product is a liquid skin substitute which begins to gel in the body in about ~10 minutes.
Derived from our CXU ECM Scaffold Technology, it is an innovative skin substitute. It enhances tissue regeneration with a faster rate of wound healing and superior epithelialization.
Clinically demonstrating improved cell survival post-transplant, leading to scarless and non-fibrotic healing and effectively reduces inflammation, requiring fewer cells for better outcomes with fewer complications.
Optimized For Tissue Integration
Conexeu Sciences' first product is a liquid skin substitute which begins to gel in the body in about ~10 minutes.
Derived from our CXU ECM Scaffold Technology, it is an innovative skin substitute. It enhances tissue regeneration with a faster rate of wound healing and superior epithelialization.
Clinically demonstrating improved cell survival post-transplant, leading to scarless and non-fibrotic healing and effectively reduces inflammation, requiring fewer cells for better outcomes with fewer complications.
Optimized For Tissue Integration
Conexeu Sciences' first product is a liquid skin substitute which begins to gel in the body in about ~10 minutes.
Derived from our CXU ECM Scaffold Technology, it is an innovative skin substitute. It enhances tissue regeneration with a faster rate of wound healing and superior epithelialization.
Clinically demonstrating improved cell survival post-transplant, leading to scarless and non-fibrotic healing and effectively reduces inflammation, requiring fewer cells for better outcomes with fewer complications.
About Ten-Minute-Tissue™
Our Liquid Skin Substitute is engineered to:
- Liquid Skin Substitute (CTP) Liquid at room temperature form can form into a gel in the body in about 10 minutes. (@34 degrees)
- Once formed in place, it mimics natural organs and tissue.
- Promotes wound healing via Epithelial Advancement: Accelerating the growth of new cells for wound closure.
- Facilitate Regeneration & Repair: Supports the body’s natural healing processes, leading to more robust and faster tissue regeneration.
- Tissue Integration: Mimics natural tissue properties, ensuring high compatibility and integration with the patient’s own cells.
- Non-toxic & Non-fibrotic (scarring): Formulated to be safe, minimizing the risk of adverse reactions and preventing excessive scar tissue formation.
- Clinically Proven: Published pilot studies for wound repair (Flaps/ Mesh Skin Grafts).
Designed to address the critical stages of wound healing.
Optimized For Tissue Integration
Conexeu Sciences' first product is a liquid skin substitute which begins to gel in the body in about ~10 minutes.
Derived from our CXU ECM Scaffold Technology, it is an innovative skin substitute. It enhances tissue regeneration with a faster rate of wound healing and superior epithelialization.
Clinically demonstrating improved cell survival post-transplant, leading to scarless and non-fibrotic healing and effectively reduces inflammation, requiring fewer cells for better outcomes with fewer complications.
TECHNOLOGY ORIGIN
Our patented CXU Scaffold™ Technology is a groundbreaking advancement in regenerative medicine.
Developed at the University of British Columbia, in the BC Professional Firefighters Burn and Wound Healing Lab.
ABOUT US
Conexeu Sciences, Inc. is building a new class of wound care and aesthetic products from our innovative tissue research in regenerative medicine.
The company is leading the development and commercialization of cellular therapies for skin restoration. Ideal for applications in wound care such as burns, acute wounds and diabetic ulcers, with aesthetic indications for soft tissue fillers.
ABOUT US
Conexeu Sciences, Inc. is building a new class of wound care and aesthetic products from our innovative tissue research in regenerative medicine.
The company is leading the development and commercialization of cellular therapies for skin restoration. Ideal for applications in wound care such as burns, acute wounds and diabetic ulcers, with aesthetic indications for soft tissue fillers.